Contrast-induced nephropathy in patients with acute coronary syndrome: clinical significance, diagnosis, prophylaxis
https://doi.org/10.15829/1728-8800-2019-2255
Abstract
In modern medical practice, contrast-induced nephropathy (CIN) is an urgent problem in patients with acute coronary syndrome that underwent percutaneous interventions. It worsens prognosis, increases the number of cardiovascular complications and the length of hospital stay. Despite the use of modern radiocontrast agents, the incidence of CIN can increase in a certain patients up to 50%. Risk factors for CIN can be associated both with the patient and directly with the x-ray procedures. The diagnosis is mainly based on the pre- and postprocedural determination of creatinine. However, more modern biomarkers of kidney injury can be used at present, which allow diagnosing the acute kidney injury as soon as possible. A huge role is played not only by treatment, but also by the prevention of CIN, which consists in the timely identification of high-risk patients. The current study presents the main points of pathogenesis, methods for diagnosing CIN, as well as methods for its prevention and treatment in patients with acute coronary syndrome.
About the Authors
O. V. Demchuk
Altai Regional Cardiology Dispensary
Russian Federation
Russian Federation
Barnaul
I. A. Sukmanova
Altai Regional Cardiology Dispensary; Altai State Medical University
Russian Federation
Russian Federation
Barnaul
I. V. Ponomarenko
Altai Regional Cardiology Dispensary
Russian Federation
Russian Federation
Barnaul
V. A. Elykomov
Altai State Medical University
Russian Federation
Russian Federation
Barnaul
References
1. 2017 ESC Guidelines for themanagement of acutemyocardial infarction patients presenting with ST-segment elevation. Eur Heart J. 2018;39(38):119-77. doi:10.1093/eurheartj/ehx393.
2. Gaskina AA, Mayskov VV, Mera IA, et al. Incidence, predictors and outcomes of contrast-induced acute kidney injury in patients with acute coronary syndrome and percutaneous intervention. Kardiologiya: novosti, mneniya, obuchenie. 2015;(4):43-52. (In Russ).
3. Yang Y, George KC, Luo R, et al. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol. 2018; 19( 1 ):374. doi:10.1186/s12882-018-1161-5.
4. Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy. Journal of nephropatol. 2014; 3(2):51-6. doi:10.12860/inp.201412.
5. Kopylova JV, Poz YL, Strokov AG, et al. Acute kidney injury: historical aspects and diagnostic criteria. Russian Journal of Transplantology and Artificial Organs. 2010;12(1):94-9. (In Russ.) doi:10.15825/1995-1191-2010-1-94-99.
6. Zaitseva NV, Shamkhalova MSh, Shestakova MV, et al. Risk factors for development and ways to prevent contrast-induced nephropathy during coronary angiography in patients with type 2 diabetes. Diabetes. 2008;2:28-31. (In Russ.)
7. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int., (Suppl). 2012;2(2):1-164. doi:10.1038/kisup.2012.2.
8. Vershinina EO, Repin AN. Contrast-induced nephropathy after elective percutaneous coronary interventions. Siberian Medical J. 2016;31(3):61-7 (In Russ.) doi:10.29001/2073-8552-2016-31-3-61-67.
9. Ursta A, Kharkov E, Petrova M, et al. Contrast-induced nephropathy in subjects with acute coronary syndrome. Complex Issues of Cardiovascular Diseases. 2016;(3): 108-12. (In Russ.) doi:10.17802/2306-1278-2016-3-108-112.
10. Moiseev VC, Mukhin NA, Smirnov AV, et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology. 2014;(8):7-37 (In Russ.) doi:10.15829/1560-4071-2014-8-7-37.
11. Abe M, Morimoto T, Akao M, et al. Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary Intervention. The American Journal of Cardiology. 2014;114(3):362-8. doi:10.1016/j.amjcard.2014.05.009.
12. Volgina GV, Kozlovskaya NN, Shchekochikhin DU. Clinical guidelines for the prevention, diagnosis and treatment of contrast-induced nephropathy. Scientific Society of Nephrologists of Russia Association of Nephrologists of Russia, 2016. р.18. (In Russ.)
13. Jorgensen AL. Contrast-Induced Nephropathy: Pathophysiology and Preventive Strategies. Critical Care Nurse. 2013; 33(1):37-46. doi:10.4037/ccn2013680.
14. Shulzhenko LV, Pershukov IV, Batyraliev TA. Contrast-induced nephropathy. Focus on prevention. International Journal of Interventional Cardiology. 2010;20:47-59. (In Russ.)
15. Mohammed NA, Rafie I, Mahfouz A, et al. Contrast-induced nephropathy. Heart Views. 2013; 14(3): 106. doi: 10.4103/1995-705x125926.
16. Azzalini L, Spagnoli V, Ly HQ. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. Canadian Journal of Cardiology. 2016;32(2):247-55. doi: 10.1016/j.cjca.2015.05.013.
17. 17 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. JACC. 2004;(44):1393-9. doi:10.1016/j.jacc.2004.06.068.
18. Smirnov AV, Dobronravov VA, Rumyantsev AS, et al. National recommendations. Acute renal injury: basic principles of diagnosis, prevention and therapy. Nephrology. 2016;20(1):79-104 (In Russ.) doi: 10.22141/2307-12573.172016.76539.
19. Briguori C, Quintavalle C, Donnarumma E, Condorelli G. Novel Biomarkers for Contrast-Induced Acute Kidney Injury. BioMed Research International. 2014;1-5. doi:10.1155/2014/568738.
20. Gorda II, Bezrodnii AB, Vasilenko OV, et al. Markers of acute kidney damage. Heart and vessels. 2012;3:108-13. (In Russ.)
21. Ponomarenko IV, Sukmanova IA. Current biomarkers of kidney injury: Clinical and prognostic significance. Russian Heart J. 2017; 16(3): 168-76. (In Russ.) doi:10.17802/2306-1278-2017-6-4-44-49.
22. Kropivko TV, Druzhina AN, Loskutov OA, et al. Prevention and treatment of contrast-induced nephropathy in cardiac patients. Emergency medicine. 2015;2(65):88-91. (In Russ.)
23. Andreucci M, Faga T, Pisani A, et al. Prevention of Contrast-Induced Nephropathy through a Knowledge of Its Pathogenesis and Risk Factors. The Scientific World J. 2014; 1-16. doi:10.1155/2014/823169.
24. Dundua D, Kartashov D, Babunashvili A, et al. Is Nephropathy Inevitable in Response to Contrast Media Injection? Meditsinskaya vizualizatsiya. 2010;6:25-31. (In Russ.)
25. Vitor OG, Ricardo L, Valter C. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial. Arquivos Brasileiros de Cardiologia. 2012;99(6).
26. Neumann FJ, Miguel SA, Fernando A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394.
27. 27 Gandhi, S., Mosleh, W., Abdel-Qadir, H., et al. Statins and Contrast-induced Acute Kidney Injury with Coronary Angiography. The American Journal of Medicine. 2014;127(10):987-1000. doi:10.1016/j.amjmed.2014.05.011.
28. Leoncini M, Toso A, Maioli M, et al. Early highdose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome) Journal of the American College of Cardiology. 2014;63( 1 ):71-9. doi: 10.1016/j.jacc.2013.04.105.
29. Patti G, Ricottini E, Nusca A, et al. Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDACIN [atorvastatin for reduction of myocardial damage during angioplasty-contrastinduced nephropathy] trial. The American Journal of Cardiology. 2011; 108(1): 1-7. doi: 10.1016/j.amjcard.2011.03.001.
30. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation. 2011; 124(11):1250-9.
Review
For citations:
Demchuk O.V., Sukmanova I.A., Ponomarenko I.V., Elykomov V.A. Contrast-induced nephropathy in patients with acute coronary syndrome: clinical significance, diagnosis, prophylaxis. Cardiovascular Therapy and Prevention. 2020;19(2):2255. (In Russ.) https://doi.org/10.15829/1728-8800-2019-2255
Views:
1257
Email this article 
